In: The American Journal of Clinical Nutrition, 2016, vol. 103, no. 2, p. 348-355
|
In: Journal of Muscle Research and Cell Motility, 2015, vol. 36, no. 4-5, p. 297-300
|
In: Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, vol. 388, no. 12, p. 1283-1292
|
In: Human Molecular Genetics, 2017, vol. 26, no. 2, p. 320-332
|
In: The American Journal of Clinical Nutrition, 2017, vol. 105, no. 3, p. 609-617
|
In: Cancers, 2020, vol. 12, no. 3, p. 532
Poly(ADP-ribose) polymerase (PARP) inhibitors have recently been introduced in the therapy of several types of cancers not responding to conventional treatments. However, de novo and acquired PARP inhibitor resistance is a significant limiting factor in the clinical therapy, and the underlying mechanisms are not fully understood. Activity of the cytoprotective phosphatidylinositol-3 kinase...
|
In: Cells, 2019, vol. 8, no. 5, p. 388
Fluid shear stress stimulates endothelial nitric oxide synthase (eNOS) activation and nitric oxide (NO) production through multiple kinases, including protein kinase A (PKA), AMP-activated protein kinase (AMPK), AKT and Ca2+/calmodulin-dependent protein kinase II (CaMKII). Membrane-associated guanylate kinase (MAGUK) with inverted domain structure-1 (MAGI1) is an adaptor protein that...
|
In: Diabetologia, 2014, vol. 57, no. 5, p. 1001-1005
|
In: Heart Failure Reviews, 2014, vol. 19, no. 6, p. 815-824
|
In: Hormone Molecular Biology and Clinical Investigation, 2016, vol. 28, no. 1, p. 39-53
|